Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 28 Feb 2023 Mini review · 30 Nov 2022 Phase 0 Trials and FDA and EMEA Standardsandprime; Impact on Drug Development
produced by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Who is involved in the development of the guideline and what specific trial design recommendations ... they provide are…
Mini review · 31 Aug 2022 The Influence of FDA and EMEA Standards on Drug Development in Phase 0 Trials
produced by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Who is involved in the development of the guideline and what specific trial design recommendations ... they provide are…
Mini review · 2 Aug 2022 Influenza a Virus Infections at Several Stages of In Vitro and Ex Vivo Infection are Significantly Decreased by Rtk/Raf Signaling Inhibitors Approved by the Fda
In this paper, community HCWs in the southwest Chinese city of Chongqing
Perspective · 14 Apr 2022 FDA Drives Planned to Bridle Data Innovation to Modernize the Administrative Cycle
Commentary · 6 Apr 2022 A Note on Food and Drug Administration (FDA)
Commentary · 29 Mar 2022 An overview on food and drug administration (FDA)
Conference abstract · 21 Mar 2022 Using an FDA approved nutrition supplement, intralipid, to improve delivery of anti-cancer nanodrugs: Effects on RES clearance and toxicity, EPR and immune modulation
have developed a method to temporarily blunt the RES by pre- administration of the FDA-approved nutritional supplement, Intralipid® (2-6). We have tested our Intralipid® method ... platinum (II)-loaded and hyaluronic…
Conference abstract · 21 Feb 2022 New Concepts for Drug Product Innovation & Novel Excipients - FDA Novel Excipient Pilot Program
horizon which could help resolve these uncertainties. On September 7, 2021, The U.S. FDA's Center for Drug Evaluation and Research (CDER) launched the voluntary Novel Excipient Review Pilot Program ... Pilot Program)…
Opinion · 28 Jan 2022 Remedy Hallucinogenics: The Street from FDA Endorsement to Clinical Practice.
Mini review · 2022 Phase 0 Trials and FDA and EMEA Standards′ Impact on Drug Development
Conference abstract · 2022 Using an FDA approved nutrition supplement, intralipid, to improve delivery of anticancer nanodrugs: Effects on RES clearance and toxicity, EPR and immune modulation
have developed a method to temporarily blunt the RES by pre- administration of the FDA-approved nutritional supplement, Intralipid® (2-6). We have tested our Intralipid® method ... platinum (II)-loaded and hyaluronic…
Short communication · 26 Nov 2021 A Brief Outline on FDA Adverse Event Reporting System its Limitations and Uses
Research article · 21 Oct 2021 Post-Marketing Change in Dosage and Administrations of FDA-Approved Drugs Between 2000 and 2017
marketing dosage changes using labeling information for New Molecular Entities (NMEs) approved by the FDA. Methods: We compiled a list of NMEs approved by the FDA between January ... December 31, 2017, using the FDA’s…
Review article · 27 Sep 2021 In-silico pharmacological studies and RMSD comparison of FDA drugs with bioactive compounds in musa paradisica for ligand promotion.
This study includes Bio-Pharmaceutical research for atomic demonstrating techniques, inside an
Conference abstract · 31 Aug 2021 A convergence of regulatory policies at FDA and EMA
USFDA followed suit in August 2011 with the‘Advancing Regulatory Science Strategic Plan’. The FDA indicated that it will also mandate similar standards by 2015. Most important global pharmaceutical regulatory
Mini review · 25 Aug 2021 The New FDA Approved Drug for Alzheimer’s disease, Aducanumab, and what Patients should know?
Editorial · 6 Jun 2021 A Broken Regulatory System: Only 2% of Medical Devices used in the United States are FDA-Approved
trained and licensed surgeons, they are very likely thinking of FDAApproved medical devices. FDA Approval incorporates rigorous preclinical research such as: cadaver, animal, mechanical, materials and stress testing…
Short communication · 25 Mar 2021 A Note on Medications, Devices and FDA
Editorial · 23 Mar 2021 The FDA has Approved a Choice Tool for Breast Reconstruction Research
Research article · 27 Jan 2021 Are Women Underrepresented in Cerebrovascular Disease Clinical Trials? A Systematic Review using the FDA Database
purpose: Clinical trials provide essential evidence in the US Food and Drug Administration (FDA) drug approval process. Women were underrepresented in the enrollment of clinical trials for many medical conditions…
Conference abstract · 2021 FDA cGMP Requirements for Combination Products â?? Considerations for Drug Manufacturers
Conference abstract · 2021 FDA cGMP Requirements for Combination Products – Considerations for Drug Manufacturers
Research article · Sep 2020 Biosimilars Interchangeability in the USA: The Final US-FDA Guidance to Industry
Editorial · 27 Aug 2020 FDA Considers Sertindole, a SecondGeneration Antipsychotic
antipsychotic that was previously reviewed by the United States Food and Drug Administration (FDA) in the late 1990s, has recently been submitted as a new drug application for consideration

